Lesinurad + XOI + Placebo + colchicine + corticosteroids
ApprovedTerminated 0 watching 0 views this week๐ฅ Hot
82
Development Stage
โ
Pre-clinicalโ
Phase 1โ
Phase 2โ
Phase 35
ApprovedIndication / Disease
Gout
Conditions
Gout, Chronic Kidney Disease (CKD)
Trial Timeline
Jul 19, 2017 โ Feb 25, 2019
NCT ID
NCT03226899About Lesinurad + XOI + Placebo + colchicine + corticosteroids
Lesinurad + XOI + Placebo + colchicine + corticosteroids is a approved stage product being developed by Medpace for Gout. The current trial status is terminated. This product is registered under clinical trial identifier NCT03226899. Target conditions include Gout, Chronic Kidney Disease (CKD).
Hype Score Breakdown
Clinical
30
Activity
20
Company
7
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03226899 | Approved | Terminated |
Competing Products
20 competing products in Gout